These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Editorial comment: boosted PIs and metabolism--it's not just the ritonavir. Moyle GJ AIDS Read; 2005 Oct; 15(10):531. PubMed ID: 16265769 [No Abstract] [Full Text] [Related]
3. Hyperlipidemia associated with the use of protease inhibitors. Smith JH; Martin GJ; Decker CF Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432 [No Abstract] [Full Text] [Related]
4. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks. Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J; Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443 [TBL] [Abstract][Full Text] [Related]
5. Revision of ritonavir starting dose. AIDS Patient Care STDS; 1996 Aug; 10(4):261. PubMed ID: 11361602 [No Abstract] [Full Text] [Related]
6. Improved tolerability and quality of life with the new lopinavir/ritonavir tablet formulation. Olmo M; Ferrer E; Curto J; Barragán P; Saumoy M; Perulero N; Podzamczer D J Infect; 2008 Dec; 57(6):503-5. PubMed ID: 18952298 [No Abstract] [Full Text] [Related]
7. Acute generalized exanthematous pustulosis induced by HIV postexposure prophylaxis with lopinavir-ritonavir. Ghosn J; Duvivier C; Tubiana R; Katlama C; Caumes E Clin Infect Dis; 2005 Nov; 41(9):1360-1. PubMed ID: 16206117 [No Abstract] [Full Text] [Related]
8. Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia. Brown CA; Lesher JL; Peterson CM J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S86-9. PubMed ID: 15858517 [TBL] [Abstract][Full Text] [Related]
9. Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome. Kikuchi Y; Genka I; Ishizaki A; Sunagawa K; Yasuoka A; Oka S Clin Infect Dis; 2002 Aug; 35(4):488-90. PubMed ID: 12145735 [TBL] [Abstract][Full Text] [Related]
10. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Chaubey SK; Sinha AK; Phillips E; Russell DB; Falhammar H Sex Health; 2009 Sep; 6(3):254-7. PubMed ID: 19653965 [TBL] [Abstract][Full Text] [Related]
11. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen. Clevenbergh P; Corcostegui M; Gérard D; Hieronimus S; Mondain V; Chichmanian RM; Sadoul JL; Dellamonica P J Infect; 2002 Apr; 44(3):194-5. PubMed ID: 12099750 [TBL] [Abstract][Full Text] [Related]
12. Changes to Norvir labeling. AIDS Patient Care STDS; 2008 Oct; 22(10):834-5. PubMed ID: 18924248 [No Abstract] [Full Text] [Related]
13. Ritonavir-boosted protease inhibitors, Part 2: cardiac implications of lipid alterations. Cohen CJ AIDS Read; 2005 Oct; 15(10):528-32, 537-8. PubMed ID: 16265768 [TBL] [Abstract][Full Text] [Related]